By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


iBio, Inc. 

9 Innovation Way
Suite 100
Newark  Delaware  19711  U.S.A.
Phone: 302-355-0650 Fax: 302-356-1173


Company News
iBio, Inc. (IBIO) Enters Into Common Stock Purchase Agreement For Up To $16.0 Million With Lincoln Park Capital 7/24/2017 11:13:33 AM
iBio, Inc. (IBIO) Provides Corporate Update At Annual Shareholders Meeting 5/5/2017 11:27:59 AM
Another iBio, Inc. (IBIO) Plague Vaccine Patent Issues 11/22/2016 9:58:31 AM
iBio, Inc. (IBIO) Expands Product Development Capacity Of cGMP Plant 11/15/2016 10:51:11 AM
iBio, Inc. (IBIO) Proprietary Technology Advances Neonatal Respiratory Distress Syndrome Drug Development For South African Biotech Company AzarGen Biotechnologies (Pty) Ltd 9/29/2016 11:31:34 AM
Implications Of Court Decision In Favor Of iBio, Inc. (IBIO) Against Fraunhofer 8/17/2016 10:12:22 AM
iBio, Inc. (IBIO)'s Claims Against Fraunhofer Affirmed By Delaware Chancery Court 8/5/2016 10:43:08 AM
iBio, Inc. (IBIO) Receives FDA Orphan Drug Designation For Fibrosis Product Candidate 7/5/2016 12:35:25 PM
iBio, Inc. (IBIO) Receives New Patent For Its Biotherapeutic Products For Treatment Of Fibrosis 6/30/2016 12:16:12 PM
Texas A&M University System And iBio, Inc. (IBIO) Execute Joint Development Agreement For Plant-Produced Pharmaceuticals 6/7/2016 9:17:27 AM